Lucio Pastore

Prof. Dr. Lucio Pastore

Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via S. Pansini 5, 80131 Naples, Italy
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1997 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BLBrendan Lee
Brendan Lee
KTKannan Thirunavukkarasu
Kannan Thirunavukkarasu
LZLei Zhou
Lei Zhou
LPLucio Pastore
Lucio Pastore
Antonio BaldiniAntonio Baldini
Antonio Baldini
GKGerard Karsenty
Gerard Karsenty

10 November 2020 in Lung
Verified
Journal Article
Open access
PDF file
FSFilippo Scialo
Filippo Scialo
ADAurora Daniele
Aurora Daniele
FAFelice Amato
Felice Amato
LPLucio Pastore
Lucio Pastore
MMMaria Gabriella Matera
Maria Gabriella Matera
ABAndrea Bianco
Andrea Bianco
Despite the unprecedented effort of the scientific community, the novel SARS-CoV-2 virus has infected more than 46 million people worldwide, killing over one million two hundred thousand. Understanding the mechanisms by which some individuals are more susceptible to SARS-CoV-2 infection and why a subgroup of them are prone to experience severe pneumonia, and death should lead to a better approach and more effective treatments for COVID-19. Here, we focus our attention on ACE2, a primary receptor of SARS-CoV-2. We will discuss its biology, tissue expression, and post-translational regulation that determine its potential to be employed by SARS-CoV-2 for cell entry. Particular attention will be given to how the ACE2 soluble form can have a great impact on disease progression and thus be used in a potential therapeutic strategy. Furthermore, we will discuss repercussions that SARS-CoV-2/ACE2 binding has on the renin–angiotensin system and beyond. Indeed, although mostly neglected, ACE2 can also act on [des-Arg 937]-bradykinin of the kinin–kallikrein system regulating coagulation and inflammation. Thorough comprehension of the role that ACE2 plays in different pathways will be the key to assess the impact that SARS-CoV-2/ACE2 binding has on organismal physiology and will help us to find better therapies and diagnostic tools.

1 November 2010 in Obesity
Verified
Journal Article
Closed access
PDF file
Rosanna MartinelliRosanna Martinelli
Rosanna Martinelli
CNCarmela Nardelli
Carmela Nardelli
VPVincenzo Pilone
Vincenzo Pilone
TBTonia Buonomo
Tonia Buonomo
RLRosario Liguori
Rosario Liguori
LSLucia Sacchetti
Lucia Sacchetti

20 November 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Cristina MazzaccaraCristina Mazzaccara
Cristina Mazzaccara
GLGiuseppe Labruna
Giuseppe Labruna
GCGennaro Cito
Gennaro Cito
MSMarzia Scarfò
Marzia Scarfò
MFMario De Felice
Mario De Felice
LSLucia Sacchetti
Lucia Sacchetti
Although the mouse is the animal model most widely used to study the pathogenesis and treatment of human diseases, reference values for biochemical parameters are scanty or lacking for the most frequently used strains. We therefore evaluated these parameters in the C57BL/6J, 129SV/EV and C3H/HeJ mice. We measured by dry chemistry 26 analytes relative to electrolyte balance, lipoprotein metabolism, and muscle/heart, liver, kidney and pancreas functions, and by automated blood counter 5 hematological parameters in 30 animals (15 male and 15 female) of each mouse strain at three age ranges: 1–2 months, 3–8 months and 9–12 months. Whole blood was collected from the retro-orbital sinus. We used quality control procedures to investigate analytical imprecision and inaccuracy. Reference values were calculated by non parametric methods (median and 2.5th and 97.5th percentiles). The Mann-Whitney and Kruskal-Wallis tests were used for between-group comparisons. Median levels of GLU, LDH, Chol and BUN were higher, and LPS, AST, ALP and CHE were lower in males than in females (p range: 0.05–0.001). Inter-strain differences were observed for: (1) GLU, t-Bil, K+, Ca++, PO4− (p<0.05) and for TAG, Chol, AST, Fe++ (p<0.001) in 4–8 month-old animals; (2) for CK, Crea, Mg++, Na++, K+, Cl− (p<0.05) and BUN (p<0.001) in 2- and in 10–12 month-old mice; and (3) for WBC, RBC, HGB, HCT and PLT (p<0.05) during the 1 year life span. Our results indicate that metabolic variations in C57BL/6J, 129SV/EV and C3H/HeJ mice after therapeutic intervention should be evaluated against gender- and age-dependent reference intervals.

25 November 2005 in Circulation Research
Verified
Journal Article
Closed access
Guido IaccarinoGuido Iaccarino
Guido Iaccarino
Michele CiccarelliMichele Ciccarelli
Michele Ciccarelli
DSDaniela Sorriento
Daniela Sorriento
Gennaro GalassoGennaro Galasso
Gennaro Galasso
ACAlfonso Campanile
Alfonso Campanile
BTBruno Trimarco
Bruno Trimarco
β2-Adrenergic receptors (β2ARs) are widely expressed, although their physiological relevance in many tissues is not yet fully understood. In vascular endothelial cells, they regulate NO release and vessel tone. Here we provide novel evidence that β2ARs can regulate neoangiogenesis in response to chronic ischemia. We used in vivo adenoviral-mediated gene transfer of the human β2AR to the endothelium of the rat femoral artery and increased β2AR signaling resulting in ameliorated angiographic blood flow and hindlimb perfusion after chronic ischemia. Histological analysis confirmed that β2AR overexpression also produced benefits on capillary density. The same maneuver partially rescued impaired angiogenesis in spontaneously hypertensive rats (SHR), whereas gene delivery of the G-protein–coupling defective mutant Ile164 β2AR failed to provide ameliorations. Stimulation of endogenous and overexpressed β2AR on endothelial cells in vitro was found to regulate cell number by inducing proliferation and [3H]-thymidine incorporation through means of extracellular receptor-activated kinase and vascular endothelial growth factor. The β2AR also has novel effects on endothelial cell number through stimulation of proapoptosis and antiapoptosis pathways involving p38 mitogen-activated protein kinase and PI3-kinase/Akt activation. Therefore, β2ARs play a critical role in endothelial cell proliferation and function including revascularization, suggesting a novel and physiologically relevant role in neoangiogenesis in response to ischemia.

20 July 1999 in Human Gene Therapy
Verified
Journal Article
Closed access
LPLucio Pastore
Lucio Pastore
NMNúria Morral
Núria Morral
HZHeshan Zhou
Heshan Zhou
RGRacel Garcia
Racel Garcia
RPRobin J. Parks
Robin J. Parks
ABArthur L. Beaudet
Arthur L. Beaudet
Previous studies using adenoviral (Ad) vectors expressing human alpha1-antitrypsin (hAAT) under the control of ubiquitous promoters (RSV, mPGK) elicited the production of antibodies to hAAT in some mouse strains (C3H/HeJ and BALB/c) but not in others (C57BL/6J). In contrast, when a helper-dependent Ad vector (AdSTK109) with all viral coding sequences deleted and expressing hAAT from human genomic DNA with the endogenous promoter was used, C3H/HeJ mice failed to develop antibodies and demonstrated long-term expression. These results suggested that promoter choice and/or properties of the vector itself might influence the host immune response to the transgene product. Direct comparison of first-generation vectors expressing the hAAT cDNA from a ubiquitous mouse PGK promoter rather than from a liver-specific mouse albumin promoter demonstrated that an antibody response to hAAT occurred with the mPGK promoter but not with the albumin promoter in C3H/HeJ mice. As expected, neither vector elicits an antibody response in C57BL/6J mice. Coinjection of the two first-generation vectors containing the mPGK and albumin promoter in C3H/HeJ mice induced an antibody response with resulting loss of detectable hAAT from the sera of the injected mice in 3-4 weeks. From these data, we conclude that under certain conditions, the choice of promoter with its associated liver-specific expression can modulate the host immune response to the transgene independent of viral backbone.